Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT
The IMPACT trial evaluating the effect of antimalarials, including hydroxychloroquine, on COVID-19 infections has completed in patients with…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? [NA]
This clinical trial investigated whether patients with skin psoriasis have subclinical features of active psoriatic arthritis detected by mu…
-
FDA approval · 2024-09-11FDA Approved: TREMFYA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for TREMFYA (guselkumab) submitted by Janssen Biotech, Inc., affecting the drug's approved labeling …
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating sonelokimab for active psoriatic arthritis has been completed.
-
CLINICAL_TRIALS other · 2024-09-04Clinical Trial Update: Cytokine Expression in Psoriasis Patients with and Without Joint Involvement [NA]
A clinical trial investigating cytokine expression in psoriasis patients with and without psoriatic arthritis, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Validation of Handheld Ultrasound Devices in Rheumatology
A completed clinical trial evaluating the validity of handheld ultrasound devices for assessing Psoriatic arthritis in rheumatology, sponsor…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Korean Post-marketing Surveillance for Xeljanz
Korean post-marketing surveillance study for Xeljanz (tofacitinib) has completed and the results have been posted.
-
FDA approval · 2024-08-26FDA Approved: ADALIMUMAB-RYVK — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for ADALIMUMAB-RYVK, a biosimilar to adalimumab, submitted by Quallent Pharmaceuticals Health LL…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy [NA]
Clinical trial update on integrating remote monitoring into chronic immunosuppressive therapy for rheumatoid arthritis, psoriatic arthritis,…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients
Completed clinical trial evaluating serum M2BP and musculoskeletal ultrasound as predictors of arthritis in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. [Phase 3]
Phase 3 trial results assessing the efficacy and safety of secukinumab versus placebo in Chinese patients with active psoriatic arthritis; r…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis [Phase 2]
The document describes an ongoing Phase 2 clinical trial evaluating HS-10374 versus placebo for active psoriatic arthritis, with recruitment…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis
A completed clinical trial evaluating how Upadacitinib affects disease state in adults with oligo- or poly-articular psoriatic arthritis.
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
An active pharmacovigilance study is being conducted to monitor the safety of Rinvoq (upadacitinib) in inflammatory diseases. Recruitment fo…
-
FDA approval · 2024-06-28FDA Approved: USTEKINUMAB-TTWE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approves a new biologic product, ustekinumab-tTWE, from Quallent Pharmaceuticals Health LLC, via an Original Biologics License Applicati…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
An update on a clinical trial aimed at characterizing the immunogenicity of TNF inhibitors in arthritis patients with poorer treatment respo…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
Clinical trial SAPHIR assesses predictive factors for persistence of adalimumab treatment after switching from reference product to Freseniu…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Hand Exercises in Psoriatic Arthritis [NA]
A completed clinical trial studying hand exercises for psoriatic arthritis conducted by Akdeniz University.
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)
A completed real-world study evaluating the effectiveness, safety and tolerability of Apremilast for psoriatic arthritis in Canadian routine…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment
The clinical trial sponsored by Amgen evaluated apremilast in biologic-naïve patients with psoriatic arthritis and has completed.
-
FDA approval · 2024-06-03FDA Approved: METHOTREXATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for methotrexate, authorizing the generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating NDI-034858 in active psoriatic arthritis has completed. Results have been posted.
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis
This study is currently recruiting to evaluate sarcopenia and related factors in patients diagnosed with psoriatic arthritis.
-
FDA approval · 2024-05-14FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) from Pfizer, granting an additional regulatory action under NDA 213082.
-
FDA approval · 2024-05-14FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for XELJANZ XR (tofacitinib) from Pfizer, introducing the extended-release formulation. Submission s…